| Year |
Citation |
Score |
| 2007 |
Huang L, Min JN, Masters S, Mivechi NF, Moskophidis D. Insights into function and regulation of small heat shock protein 25 (HSPB1) in a mouse model with targeted gene disruption. Genesis (New York, N.Y. : 2000). 45: 487-501. PMID 17661394 DOI: 10.1002/Dvg.20319 |
0.366 |
|
| 2006 |
Du Y, Masters SC, Khuri FR, Fu H. Monitoring 14-3-3 protein interactions with a homogeneous fluorescence polarization assay. Journal of Biomolecular Screening. 11: 269-76. PMID 16699128 DOI: 10.1177/1087057105284862 |
0.639 |
|
| 2004 |
Masters SC. Internet resources for studying protein-protein interactions. Methods in Molecular Biology (Clifton, N.J.). 261: 519-24. PMID 15064480 DOI: 10.1385/1-59259-762-9:519 |
0.412 |
|
| 2004 |
Masters SC. Co-immunoprecipitation from transfected cells. Methods in Molecular Biology (Clifton, N.J.). 261: 337-50. PMID 15064468 DOI: 10.1385/1-59259-762-9:337 |
0.514 |
|
| 2004 |
Chen J, Williams IR, Kutok JL, Duclos N, Anastasiadou E, Masters SC, Fu H, Gilliland DG. Positive and negative regulatory roles of the WW-like domain in TEL-PDGFbetaR transformation. Blood. 104: 535-42. PMID 15054045 DOI: 10.1182/Blood-2004-01-0169 |
0.563 |
|
| 2003 |
Hamaguchi A, Suzuki E, Murayama K, Fujimura T, Hikita T, Iwabuchi K, Handa K, Withers DA, Masters SC, Fu H, Hakomori S. A sphingosine-dependent protein kinase that specifically phosphorylates 14-3-3 (SDK1) is identified as the kinase domain of PKCδ: A preliminary note Biochemical and Biophysical Research Communications. 307: 589-594. PMID 12893264 DOI: 10.1016/S0006-291X(03)01070-2 |
0.579 |
|
| 2003 |
Hamaguchi A, Suzuki E, Murayama K, Fujimura T, Hikita T, Iwabuchi K, Handa K, Withers DA, Masters SC, Fu H, Hakomori S. Sphingosine-dependent Protein Kinase-1, Directed to 14-3-3, Is Identified as the Kinase Domain of Protein Kinase Cδ Journal of Biological Chemistry. 278: 41557-41565. PMID 12855683 DOI: 10.1074/Jbc.M305294200 |
0.604 |
|
| 2002 |
Truong AB, Masters SC, Yang H, Fu H. Role of the 14-3-3 C-terminal loop in ligand interaction. Proteins. 49: 321-5. PMID 12360521 DOI: 10.1002/Prot.10210 |
0.694 |
|
| 2002 |
Masters SC, Subramanian RR, Truong A, Yang H, Fujii K, Zhang H, Fu H. Survival-promoting functions of 14-3-3 proteins. Biochemical Society Transactions. 30: 360-5. PMID 12196095 DOI: 10.1042/Bst0300360 |
0.753 |
|
| 2002 |
Masters SC, Subramanian RR, Truong A, Yang H, Fujii K, Zhang H, Fu H. Prosurvival Function of 14-3-3 Proteins Biochemical Society Transactions. 30: A62-A62. DOI: 10.1042/Bst030A062A |
0.706 |
|
| 2001 |
Masters SC, Yang H, Datta SR, Greenberg ME, Fu H. 14-3-3 inhibits Bad-induced cell death through interaction with serine-136. Molecular Pharmacology. 60: 1325-31. PMID 11723239 DOI: 10.1124/Mol.60.6.1325 |
0.65 |
|
| 2001 |
Subramanian RR, Masters SC, Zhang H, Fu H. Functional conservation of 14-3-3 isoforms in inhibiting bad-induced apoptosis. Experimental Cell Research. 271: 142-51. PMID 11697890 DOI: 10.1006/Excr.2001.5376 |
0.757 |
|
| 2001 |
Masters SC, Fu H. 14-3-3 proteins mediate an essential anti-apoptotic signal. The Journal of Biological Chemistry. 276: 45193-200. PMID 11577088 DOI: 10.1074/Jbc.M105971200 |
0.683 |
|
| 2001 |
Yang H, Masters SC, Wang H, Fu H. The proapoptotic protein Bad binds the amphipathic groove of 14-3-3zeta. Biochimica Et Biophysica Acta. 1547: 313-9. PMID 11410287 DOI: 10.1016/S0167-4838(01)00202-3 |
0.735 |
|
| 2001 |
Chiang CW, Harris G, Ellig C, Masters SC, Subramanian R, Shenolikar S, Wadzinski BE, Yang E. Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin- 3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation. Blood. 97: 1289-97. PMID 11222372 DOI: 10.1182/Blood.V97.5.1289 |
0.702 |
|
| 2000 |
Athwal GS, Lombardo CR, Huber JL, Masters SC, Fu H, Huber SC. Modulation of 14-3-3 protein interactions with target polypeptides by physical and metabolic effectors. Plant & Cell Physiology. 41: 523-33. PMID 10845467 DOI: 10.1093/Pcp/41.4.523 |
0.622 |
|
| 2000 |
Fu H, Subramanian RR, Masters SC. 14-3-3 proteins: structure, function, and regulation. Annual Review of Pharmacology and Toxicology. 40: 617-47. PMID 10836149 DOI: 10.1146/Annurev.Pharmtox.40.1.617 |
0.762 |
|
| 1999 |
Zhang L, Wang H, Masters SC, Wang B, Barbieri JT, Fu H. Residues of 14-3-3 zeta required for activation of exoenzyme S of Pseudomonas aeruginosa. Biochemistry. 38: 12159-64. PMID 10508420 DOI: 10.1021/Bi991019L |
0.608 |
|
| 1999 |
Masters SC, Pederson KJ, Zhang L, Barbieri JT, Fu H. Interaction of 14-3-3 with a nonphosphorylated protein ligand, exoenzyme S of Pseudomonas aeruginosa. Biochemistry. 38: 5216-21. PMID 10213629 DOI: 10.1021/Bi982492M |
0.677 |
|
| 1998 |
Petosa C, Masters SC, Bankston LA, Pohl J, Wang B, Fu H, Liddington RC. 14-3-3zeta binds a phosphorylated Raf peptide and an unphosphorylated peptide via its conserved amphipathic groove. The Journal of Biological Chemistry. 273: 16305-10. PMID 9632691 DOI: 10.1074/jbc.273.26.16305 |
0.542 |
|
| 1998 |
Yang H, Masters SC, Wang H, Fu H. Death agonist bad and raf-1 kinase interact with 14-3-3 through a common site Faseb Journal. 12. |
0.4 |
|
| 1998 |
Subramanian RR, Yang H, Wjicox JN, Masters SC, Fu H. Isoform specificity of 14-3-3 proteins Faseb Journal. 12. |
0.724 |
|
| 1997 |
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91: 231-41. PMID 9346240 DOI: 10.1016/S0092-8674(00)80405-5 |
0.57 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2016 |
Slough C, Masters SC, Hurley RA, Taber KH. Clinical Positron Emission Tomography (PET) Neuroimaging: Advantages and Limitations as a Diagnostic Tool. The Journal of Neuropsychiatry and Clinical Neurosciences. 28: A4-71. PMID 27093383 DOI: 10.1176/Appi.Neuropsych.16030044 |
0.196 |
|
| 2021 |
Anklam E, Bahl MI, Ball R, Beger RD, Cohen J, Fitzpatrick S, Girard P, Halamoda-Kenzaoui B, Hinton D, Hirose A, Hoeveler A, Honma M, Hugas M, Ishida S, Kass GE, ... ... Masters S, et al. Emerging technologies and their impact on regulatory science. Experimental Biology and Medicine (Maywood, N.J.). 15353702211052280. PMID 34783606 DOI: 10.1177/15353702211052280 |
0.053 |
|
| 2022 |
Wang SJ, Fotenos A, Masters SC, Marzella L. Theranostics approach in drug development: is there study efficiency when the prevalence of the molecular target is very high? Theranostics. 12: 3079-3083. PMID 35547778 DOI: 10.7150/thno.71788 |
0.035 |
|
| 1995 |
Norman RJ, Masters SC, Hague W, Beng C, Pannall P, Wang JX. Metabolic approaches to the subclassification of polycystic ovary syndrome Fertility and Sterility. 63: 329-335. PMID 7843439 |
0.032 |
|
| 1995 |
Norman RJ, Hague WM, Masters SC, Wang XJ. Endocrinology: Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome Human Reproduction. 10: 2258-2261. PMID 8530647 DOI: 10.1093/OXFORDJOURNALS.HUMREP.A136280 |
0.032 |
|
| 2019 |
Wong TZ, Benefield T, Masters SC, Kiser JW, Crowley JR, Osborne D, Mawlawi O, Barnwell J, Gupta P, Mintz A, Ryan KA, Perrin SR, Lattanze RK, Townsend DW. Findings from Quality Improvement Initiatives to Assess and Improve PET/CT FDG Injection Infiltration Rates in Multiple Centers. Journal of Nuclear Medicine Technology. PMID 31182666 DOI: 10.2967/jnmt.119.228098 |
0.028 |
|
| 2023 |
Nelson BJ, Kc P, Badal A, Jiang L, Masters SC, Zeng R. Pediatric evaluations for deep learning CT denoising. Medical Physics. PMID 38127330 DOI: 10.1002/mp.16901 |
0.017 |
|
| 2021 |
Masters SC, Hofling AA, Gorovets A, Marzella L. FDA Approves Ga 68 PSMA-11 for Prostate Cancer Imaging. International Journal of Radiation Oncology, Biology, Physics. PMID 33857629 DOI: 10.1016/j.ijrobp.2021.03.055 |
0.012 |
|
| Hide low-probability matches. |